Cat.No. | Name | Information |
---|---|---|
M21575 | Ervogastat | Ervogastat is a DGAT2 inhibitor that can be used in studies related to non-alcoholic steatohepatitis (NASH). |
M8388 | T863 | T863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells. |
M8069 | PF-06424439 methanesulfonate | PF-06424439 methanesulfonate is a potent and selective inhibitor of diacylglycerol acyltransferase 2 (DGAT2) with an IC50 of 14 nM. |
M6482 | AZD 3988 | AZD 3988 is a potent and selective DGAT-1 inhibitor. |
M2926 | PF-04620110 | PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM. |
M2722 | AZD7687 | AZD7687 is a reversible and selective DGAT1 inhibitor with IC50 value of 80 nM. |
M2059 | A-922500 | A-922500 (DGAT-1 Inhibitor 4a) is a potent and selective DGAT-1 inhibitor with IC50 values of 9 and 22 nM at human and mouse DGAT-1 respectively. |
M45062 | PF-07202954 | PF-07202954 is an orally active, weakly basic DGAT2 inhibitor with an IC50 of 10 nM for human DGAT2.PF-07202954 reduces hepatic triglycerides in an obese rat model. |
M40987 | ION224 | ION224 is an antisense compound that targets DGAT-2 for studies related to non-alcoholic steatohepatitis (NASH). |
M40981 | PF-07055341 | PF-07055341 is a DGAT1/2 inhibitor that can be used in studies related to non-alcoholic steatohepatitis (NASH). |
M14292 | Pradigastat | Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects. |
M14291 | DGAT-1 inhibitor 2 | DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1;antiobesity agents. |
M6850 | JNJ DGAT2-A | JNJ DGAT2-A is a dGAT2 inhibitor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.